Clinical Trial Update: Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating blinatumomab followed by high-dose chemotherapy for Ph-negative acute lymphoblastic leukemia (ALL) in adults; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Ph-negative Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic | Conditions: Lymphoblastic Leukemia, Acute, Adult, Ph Negative ALL | Phase 2 | Status: COMPLETED